Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Fuji
Cipla
Moodys
Federal Trade Commission
Citi
Merck
Chinese Patent Office

Generated: June 18, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: everolimus

« Back to Dashboard

everolimus

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis Pharm AFINITOR DISPERZ everolimus TABLET, FOR SUSPENSION;ORAL 203985 NDA Novartis Pharmaceuticals Corporation N 0078-0626-51
Novartis Pharm AFINITOR DISPERZ everolimus TABLET, FOR SUSPENSION;ORAL 203985 NDA Novartis Pharmaceuticals Corporation N 0078-0627-51
Novartis Pharm AFINITOR DISPERZ everolimus TABLET, FOR SUSPENSION;ORAL 203985 NDA Novartis Pharmaceuticals Corporation N 0078-0628-51
Novartis AFINITOR everolimus TABLET;ORAL 022334 NDA Novartis Pharmaceuticals Corporation N 0078-0566-51
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
AstraZeneca
Johnson and Johnson
Colorcon
UBS
Citi
McKesson
Federal Trade Commission